GNCA
Genocea Biosciences, Inc.
GNCA
GNCA
Delisted
GNCA was delisted on the 2nd of June, 2022.
39 hedge funds and large institutions have $77M invested in Genocea Biosciences, Inc. in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding
Funds holding: 39 → 39 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
Holders
39
Holding in Top 10
2
Calls
$1.08M
Puts
$198K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$1.67M | |
| 3 | +$448K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$429K |
| 5 |
Two Sigma Investments
New York
|
+$405K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$716K | |
| 3 | -$129K | |
| 4 |
JJIJ
Johnson & Johnson Innovation - JJDC
New Brunswick,
New Jersey
|
-$99K |
| 5 |
Squarepoint
New York
|
-$59K |